Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
- PMID: 33227656
- PMCID: PMC7648504
- DOI: 10.1016/j.thromres.2020.11.004
Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Medicines and Healthcare products Regulatory Agency (MHRA) Warfarin and other oral anticoagulants- monitoring of patients during the COVID-19 pandemic October 2020. https://www.gov.uk/government/publications/warfarin-and-other-anticoagul...
-
- England, N.H.S, Improvement, N.H.S . 2020. Clinical Guide for the Management of Anticoagulant Services During the Coronavirus Pandemic. Publications approval reference, 001559.
-
- Kaatz S., Ahmad D., Spyropoulos A.C., Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J. Thromb. Haemost. 2015;13:2119–2126. - PubMed
-
- Needham V.H. Teleconsultations compromise patient safety and professional satisfaction. bmj. 2020:370. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical